$AIMD today announced critical progress in the clinical trials of its revolutionary "Ainos Flora" volatile organic compound ("VOC") POCT device that is based upon its transformative AI-powered digital nose ("AI Nose") technology. https://www.accesswire.com/877292/ainos-unveils-critical-progress-in-ainos-flora-clinical-trials-and-next-gen-plans-powered-by-nvidia-cuda